1 / 11

Biopsy Devices Market to Reach $2,399 Million, Globally, by 2022

The global market is registering a CAGR of 5.5% during the period 2016-2022. Factors that drive the growth of biopsy devices in the developed regions are awareness about cancer diagnosis, high purchasing power, and availability of skilled personnel to perform biopsy procedures.

Abhi711
Télécharger la présentation

Biopsy Devices Market to Reach $2,399 Million, Globally, by 2022

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Biopsy Devices market Opportunity Analysis and Industry Forecast, 2016-2023 Global Opportunity Analysis and Industry Forecast, 2016-2022

  2. Introductionof Biopsy Devices market The global market is expected to garner $2,399 million by 2022, registering a CAGR of 5.5% during the period 2016-2022. Biopsy devices market is owing to increase in several types of cancer such, as breast, prostate, & lung, and rapid technological advancements in the field of diagnostics. The emerging economies have witnessed an upsurge in the prevalence of chronic diseases due to increase in the aged population and change in lifestyles. The Emergence of novel biopsy techniques and advanced integrated imaging technology, such as MRI, CT, ultrasound scan, and others, are expected to supplement the diagnosis of chronic diseases namely, cancer using biopsy procedures. However, high cost associated with advanced biopsy technologies may restrict the market growth. North America was the highest revenue generating region due to rise in incidences of chronic diseases in 2015. North America and Europe, collectively, accounted for more than three-fourths of the overall market in 2015; this trend is likely to continue over the forecast period. Factors that drive the growth of biopsy devices in the developed regions are awareness about cancer diagnosis, high purchasing power, and availability of skilled personnel to perform biopsy procedures.

  3. Introductionof Biopsy Devices market Scopeof theReport KeyBenefits KeyAudiences

  4. Key Benefits CT-guided biopsy segment is anticipated to grow at the highest CAGR of 6.3% during the forecast period. The diagnostic centers would continue to lead the revenue generating end use segment by garnering around half of the share in the overall market. Lung biopsy is projected to be the fastest growing application segment, registering a CAGR of 7.0%. The robotic guidance system segment is expected to register the highest CAGR of 7.0%. The Asia-Pacific region is projected to be the fastest growing market, with a CAGR of 7.2%. Click to Access Full Summary of Biopsy Devices Market

  5. Table of Content (TOC) Chapter: 1 Introduction Chapter: 2 Executive Summary Chapter: 3 Market Overview Chapter: 4 Market By Type Chapter: 5 Market By Application Chapter: 6 Market By Image Guided Technology Chapter: 7 Market By End Users Chapter: 8 Company Profiles

  6. Segments Biopsy Devices market

  7. Segments Biopsy Devices market

  8. Segments Biopsy Devices market

  9. Segments Biopsy Devices market

  10. Company Profiles Biopsy Devices market Leica Biosystems Boston Scientific Corporation Cook Medical, Inc. Hologic, Inc. Mauna kea technologies. Becton Dickinson and Company (Carefusion Corp.)

  11. Thank You Biopsy Devices market ThankYou! For MoreDetails Do Enquiry https://www.alliedmarketresearch.com/biopsy-devices-market Follow UsOn

More Related